illnesses

Feb. 12 (Bloomberg) -- After sifting through 4,000 existing drugs, an artificial intelligence tool helped identify a drug that successfully saved the life of a patient with idiopathic multicentric Castleman disease (iMCD). iMCD is a rare disease with extremely low survival rates and limited treatment options. According to a new paper published in the New England Journal of Medicine (NEJM), a team led by researchers at the Perelman School of Medicine at the University of Pennsylvania utilized an artificial intelligence technique called machine learning to identify adalimumab (adalim...